170 related articles for article (PubMed ID: 19269175)
1. Synthetic oligoribonucleotides containing arabinonucleotides act as agonists of TLR7 and 8.
Lan T; Bhagat L; Wang D; Dai M; Kandimalla ER; Agrawal S
Bioorg Med Chem Lett; 2009 Apr; 19(7):2044-7. PubMed ID: 19269175
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies.
Lan T; Dai M; Wang D; Zhu FG; Kandimalla ER; Agrawal S
J Med Chem; 2009 Nov; 52(21):6871-9. PubMed ID: 19824640
[TBL] [Abstract][Full Text] [Related]
3. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, purification, and characterization of oligoribonucleotides that act as agonists of TLR7 and/or TLR8.
Lan T; Kandimalla ER
Methods Mol Biol; 2011; 764():249-61. PubMed ID: 21748646
[TBL] [Abstract][Full Text] [Related]
5. Synthetic oligoribonucleotides-containing secondary structures act as agonists of Toll-like receptors 7 and 8.
Lan T; Putta MR; Wang D; Dai M; Yu D; Kandimalla ER; Agrawal S
Biochem Biophys Res Commun; 2009 Aug; 386(3):443-8. PubMed ID: 19523922
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
[TBL] [Abstract][Full Text] [Related]
7. Selective and direct activation of human neutrophils but not eosinophils by Toll-like receptor 8.
Janke M; Poth J; Wimmenauer V; Giese T; Coch C; Barchet W; Schlee M; Hartmann G
J Allergy Clin Immunol; 2009 May; 123(5):1026-33. PubMed ID: 19361845
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists.
Hamm S; Rath S; Michel S; Baumgartner R
J Immunotoxicol; 2009 Dec; 6(4):257-65. PubMed ID: 19848448
[TBL] [Abstract][Full Text] [Related]
9. CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.
Buza J; Benjamin P; Zhu J; Wilson HL; Lipford G; Krieg AM; Babiuk LA; Mutwiri GK
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):273-82. PubMed ID: 18789542
[TBL] [Abstract][Full Text] [Related]
10. Synthetic agonists of Toll-like receptors 7, 8 and 9.
Agrawal S; Kandimalla ER
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1461-7. PubMed ID: 18031246
[TBL] [Abstract][Full Text] [Related]
11. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
Lai CY; Liu YL; Yu GY; Maa MC; Leu TH; Xu C; Luo Y; Xiang R; Chuang TH
Vaccine; 2014 Sep; 32(43):5593-9. PubMed ID: 25131730
[TBL] [Abstract][Full Text] [Related]
12. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation.
Larangé A; Antonios D; Pallardy M; Kerdine-Römer S
J Leukoc Biol; 2009 Apr; 85(4):673-83. PubMed ID: 19164127
[TBL] [Abstract][Full Text] [Related]
13. The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy.
Smits EL; Ponsaerts P; Berneman ZN; Van Tendeloo VF
Oncologist; 2008 Aug; 13(8):859-75. PubMed ID: 18701762
[TBL] [Abstract][Full Text] [Related]
14. Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats.
Hammerbeck DM; Burleson GR; Schuller CJ; Vasilakos JP; Tomai M; Egging E; Cochran FR; Woulfe S; Miller RL
Antiviral Res; 2007 Jan; 73(1):1-11. PubMed ID: 16959331
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity and immune response induction of a dual agonist of Toll-like receptors 7 and 8.
Wang D; Precopio M; Lan T; Yu D; Tang JX; Kandimalla ER; Agrawal S
Mol Cancer Ther; 2010 Jun; 9(6):1788-97. PubMed ID: 20515950
[TBL] [Abstract][Full Text] [Related]
16. RNA recognition via TLR7 and TLR8.
Hornung V; Barchet W; Schlee M; Hartmann G
Handb Exp Pharmacol; 2008; (183):71-86. PubMed ID: 18071655
[TBL] [Abstract][Full Text] [Related]
17. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.
Hurst J; Prinz N; Lorenz M; Bauer S; Chapman J; Lackner KJ; von Landenberg P
Immunobiology; 2009; 214(8):683-91. PubMed ID: 19249118
[TBL] [Abstract][Full Text] [Related]
18. The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.
Smits EL; Cools N; Lion E; Van Camp K; Ponsaerts P; Berneman ZN; Van Tendeloo VF
Cancer Immunol Immunother; 2010 Jan; 59(1):35-46. PubMed ID: 19449004
[TBL] [Abstract][Full Text] [Related]
19. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
Jurk M; Kritzler A; Schulte B; Tluk S; Schetter C; Krieg AM; Vollmer J
Eur J Immunol; 2006 Jul; 36(7):1815-26. PubMed ID: 16783850
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists.
Butchi NB; Pourciau S; Du M; Morgan TW; Peterson KE
J Immunol; 2008 Jun; 180(11):7604-12. PubMed ID: 18490763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]